2022–2023 mpox outbreak in North America

2022–2023 Mpox Outbreak in North America

Stages of monkeypox lesion development

The 2022–2023 mpox outbreak in North America is part of a global outbreak of mpox, a viral disease caused by the monkeypox virus. The outbreak began in May 2022 and has affected multiple countries across the continent, with significant public health implications.

Background

Mpox, formerly known as monkeypox, is a zoonotic disease caused by the monkeypox virus, a member of the Orthopoxvirus genus. The disease is characterized by a rash that progresses through several stages, including macules, papules, vesicles, pustules, and scabs. It is similar to smallpox but generally less severe. The virus is endemic in parts of Central and West Africa, where it is transmitted to humans from animals such as rodents and primates.

Outbreak Timeline

The outbreak in North America was first identified in May 2022, with initial cases reported in the United States and Canada. The spread of the virus was facilitated by international travel and close contact among individuals, particularly in social and healthcare settings.

United States

In the United States, the Centers for Disease Control and Prevention (CDC) reported the first case in Massachusetts in May 2022. The virus quickly spread to other states, prompting public health officials to implement measures to control the outbreak. These measures included contact tracing, vaccination campaigns, and public awareness initiatives.

Canada

Canada reported its first cases in Quebec, with subsequent cases identified in other provinces. The Public Health Agency of Canada coordinated the national response, which included vaccination efforts and collaboration with international health organizations.

Transmission

Mpox is primarily transmitted through direct contact with the bodily fluids or lesions of an infected person or animal. It can also spread through respiratory droplets during prolonged face-to-face contact. The virus can survive on surfaces, making indirect transmission possible.

Symptoms

The incubation period for mpox is typically 7 to 14 days, but it can range from 5 to 21 days. Initial symptoms include fever, headache, muscle aches, and swollen lymph nodes, followed by the development of a rash. The rash progresses through several stages before forming scabs and eventually healing.

Public Health Response

The public health response to the outbreak involved a combination of vaccination, public education, and international collaboration. Vaccines such as the JYNNEOS and ACAM2000 were deployed to at-risk populations, including healthcare workers and individuals with known exposure to the virus.

Impact

The outbreak had significant social and economic impacts, affecting travel, healthcare systems, and public perception of infectious diseases. Efforts to control the outbreak highlighted the importance of global health security and the need for robust surveillance systems.

Related Pages

• Mpox
• Monkeypox virus
• Orthopoxvirus
• Zoonotic disease
• Vaccination